MedPath
FDA Approval

Levalbuterol

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 28, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Levosalbutamol(0.63 mg in 3 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

A-S Medication Solutions

A-S Medication Solutions

830016429

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levalbuterol

Product Details

NDC Product Code
50090-6377
Application Number
ANDA203653
Marketing Category
ANDA (C73584)
Route of Administration
RESPIRATORY (INHALATION)
Effective Date
August 3, 2022
Code: WDQ1526QJMClass: ACTIMQuantity: 0.63 mg in 3 mL
© Copyright 2025. All Rights Reserved by MedPath